Found: 33
Select item for more details and to access through your institution.
5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Substudy of the EnACT Trial Testing Oral Amphotericin.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 12, p. 1, doi. 10.1093/ofid/ofad596
- By:
- Publication type:
- Article
Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 11, p. 1, doi. 10.1093/ofid/ofab506
- By:
- Publication type:
- Article
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 11, p. 1, doi. 10.1093/ofid/ofaa500
- By:
- Publication type:
- Article
A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19—A Call for Clinical Trials.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 9, p. 1, doi. 10.1093/ofid/ofaa350
- By:
- Publication type:
- Article
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19).
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 4, p. N.PAG, doi. 10.1093/ofid/ofaa130
- By:
- Publication type:
- Article
Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and Outcomes.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 11, p. N.PAG, doi. 10.1093/ofid/ofz478
- By:
- Publication type:
- Article
2120. Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S717, doi. 10.1093/ofid/ofz360.1800
- By:
- Publication type:
- Article
Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 10, p. N.PAG, doi. 10.1093/ofid/ofz369
- By:
- Publication type:
- Article
Improving pharmaceutical care education in Uganda through sustainable experiential programs and research.
- Published in:
- JACCP: Journal of the American College of Clinical Pharmacy, 2020, v. 3, n. 6, p. 1085, doi. 10.1002/jac5.1255
- By:
- Publication type:
- Article
Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal Ganglia.
- Published in:
- ASN Neuro (Sage Publications, Ltd.), 2023, p. 1, doi. 10.1177/17590914231158218
- By:
- Publication type:
- Article
Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal Ganglia.
- Published in:
- ASN Neuro (Sage Publications, Ltd.), 2023, v. 15, p. 1, doi. 10.1177/17590914231158218
- By:
- Publication type:
- Article
Pharmacogenomics of COVID-19 therapies.
- Published in:
- NPJ Genomic Medicine, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41525-020-00143-y
- By:
- Publication type:
- Article
298 Identifying vaginal microbiome profiles that influence tenofovir distribution in the female genital tract.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
88462 Fluconazole distribution in CNS and gynecological tissues in HIV-related cryptococcal meningitis decedents.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Clinical pharmacology considerations and drug–drug interactions with long‐acting cabotegravir and rilpivirine relevant to sub‐Saharan Africa.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 9, p. 2079, doi. 10.1111/bcp.16154
- By:
- Publication type:
- Article
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reply to Neves.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 11, p. e835, doi. 10.1093/cid/ciaa1571
- By:
- Publication type:
- Article
Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in Preexposure Prophylaxis
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 8, p. 1717, doi. 10.1093/cid/ciz443
- By:
- Publication type:
- Article
The Complex Roadmap to Infectious Disease Innovation: The Intersection of Bugs, Drugs, and Special Populations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 4, p. 793, doi. 10.1002/cpt.2208
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID‐19 Infection.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 6, p. 1135, doi. 10.1002/cpt.1993
- By:
- Publication type:
- Article
Finding the Dose for Hydroxychloroquine Prophylaxis for COVID‐19: The Desperate Search for Effectiveness.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 766, doi. 10.1002/cpt.1874
- By:
- Publication type:
- Article
Pharmacokinetic Modelling of Efavirenz, Atazanavir, Lamivudine and Tenofovir in the Female Genital Tract of HIV-Infected Pre-Menopausal Women.
- Published in:
- Clinical Pharmacokinetics, 2012, v. 51, n. 12, p. 809, doi. 10.1007/s40262-012-0012-y
- By:
- Publication type:
- Article
Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 5, p. 574, doi. 10.1002/jcph.248
- By:
- Publication type:
- Article
Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 7, p. 494, doi. 10.1002/phar.2922
- By:
- Publication type:
- Article
Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summary
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 7, p. 488, doi. 10.1002/phar.2921
- By:
- Publication type:
- Article
Personalizing prevention: Advances in pharmacotherapy for HIV prevention.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 4, p. 305, doi. 10.1002/phar.2796
- By:
- Publication type:
- Article
Review of Real‐World Implementation Data on Emtricitabine‐Tenofovir Disoproxil Fumarate as HIV Pre‐exposure Prophylaxis in the United States.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 4, p. 486, doi. 10.1002/phar.2240
- By:
- Publication type:
- Article
Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2019, v. 46, n. 6, p. 565, doi. 10.1007/s10928-019-09657-0
- By:
- Publication type:
- Article
Pharmacology of Antiretrovirals in the Female Genital Tract for HIV Prevention.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 11, p. 1381, doi. 10.1002/jcph.1270
- By:
- Publication type:
- Article
Cerebrospinal Fluid and Brain Tissue Penetration of Tenofovir, Lamivudine, and Efavirenz in Postmortem Tissues with Cryptococcal Meningitis.
- Published in:
- CTS: Clinical & Translational Science, 2019, v. 12, n. 5, p. 445, doi. 10.1111/cts.12661
- By:
- Publication type:
- Article
A post-mortem analysis of tenofovir, lamivudine, efavirenz and fluconazole penetration in female genital tissues.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 3180, doi. 10.1093/jac/dkac300
- By:
- Publication type:
- Article